Therapeutic Approach with PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes

Authors

  • Francisco Arrieta
  • Pedro Iglesias
  • Manuel Aguilar
  • Pedro Mata
  • Juan Pedro-Botet

Abstract

Abstract not available in the source database.

Downloads

Published

2020-12-03

How to Cite

Arrieta, F., Iglesias, P., Aguilar, M., Mata, P., & Pedro-Botet, J. (2020). Therapeutic Approach with PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes. Cardiology and Cardiovascular Medicine, 4(6), 736–742. Retrieved from http://www.fortunejournals.org/ojs/index.php/ccm/article/view/15983